(Q37643115)

21 August 2017

1 reference

title

Neurooncology of familial cancer syndromes (English)

1 reference

21 August 2017

1 reference

Yasmin Khakoo

2

0 references

author name string

Andreas F Hottinger

series ordinal

1

1 reference

21 August 2017

publication date

1 December 2009

1 reference

Journal of Child Neurology

21 August 2017

published in

1 reference

21 August 2017

volume

24

1 reference

21 August 2017

issue

12

1 reference

21 August 2017

page(s)

1526-1535

1 reference

A prospective study of neurofibromatosis type 1 cancer incidence in the UK.

21 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

The neurofibromatoses: when less is more

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Neurofibromatosis type 1 revisited

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Plexiform neurofibromas in NF1: toward biologic-based therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Germline and somatic NF1 mutations in sporadic and NF1-associated malignant peripheral nerve sheath tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Guidelines for the diagnosis and management of individuals with neurofibromatosis 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Phase I trial and pharmacokinetic study of the farnesyltransferase inhibitor tipifarnib in children with refractory solid tumors or neurofibromatosis type I and plexiform neurofibromas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Chemoradiotherapy in malignant glioma: standard of care and future directions

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

von Recklinghausen neurofibromatosis. II. Incidence of optic gliomata.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

21 January 2018

Optic pathway gliomas

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Optic pathway gliomas in neurofibromatosis type 1: the effect of presenting symptoms on outcome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Optic pathway gliomas in neurofibromatosis-1: controversies and recommendations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Optic glioma in children: surveillance, resection, or irradiation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Neurofibromatosis type 1 and sporadic optic gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Natural history and clinical management of optic pathway glioma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Carboplatin and vincristine chemotherapy for children with newly diagnosed progressive low-grade gliomas.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Objective response of multiply recurrent low-grade gliomas to bevacizumab and irinotecan

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

The role of surgical biopsy in the diagnosis of glioma in individuals with neurofibromatosis-1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

The tumour-suppressor genes NF2/Merlin and Expanded act through Hippo signalling to regulate cell proliferation and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Malignant transformation and new primary tumours after therapeutic radiation for benign disease: substantial risks in certain tumour prone syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Cerebrospinal fluid leak after acoustic neuroma surgery: influence of tumor size and surgical approach on incidence and response to treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Genesis and biology of vestibular schwannomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Aggressive phenotypic and genotypic features in pediatric and NF2-associated meningiomas: a clinicopathologic study of 53 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

A role for the p53 pathway in the pathology of meningiomas with NF2 loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

The malformative central nervous system lesions in the central and peripheral forms of neurofibromatosis. A neuropathological study of 22 cases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Genotype-phenotype correlations for nervous system tumors in neurofibromatosis 2: a population-based study

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Tuberous sclerosis complex consensus conference: revised clinical diagnostic criteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

PI3K/mTORC1 activation in hamartoma syndromes: therapeutic prospects

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Managing epilepsy in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Subependymal giant cell tumors in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Central nervous system manifestations in VHL: genetics, pathology and clinical phenotypic features

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Von Hippel-Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Genotype-phenotype correlations in von Hippel-Lindau disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

The natural history of hemangioblastomas of the central nervous system in patients with von Hippel-Lindau disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Molecular insight into medulloblastoma and central nervous system primitive neuroectodermal tumor biology from hereditary syndromes: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Relative frequency and morphology of cancers in carriers of germline TP53 mutations

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Hedgehog is an early and late mediator of pancreatic cancer tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Nevoid basal cell carcinoma syndrome: relation with desmoplastic medulloblastoma in infancy. A population-based study and review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Nevoid basal cell carcinoma syndrome: review of 118 affected individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

The incidence of Gorlin syndrome in 173 consecutive cases of medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Prognostic factors and secondary malignancies in childhood medulloblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Effects of oncogenic mutations in Smoothened and Patched can be reversed by cyclopamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

The molecular basis of Turcot's syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Brain tumor-polyposis syndrome: two genetic diseases?

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Cowden syndrome: a critical review of the clinical literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Germline mutations in the PTEN/MMAC1 gene in patients with Cowden disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

Association between meningioma and Cowden's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1177%2F0883073809337539

21 January 2018

Identifiers

DOI

10.1177/0883073809337539

1 reference

21 August 2017

1 reference